Time patterns of recurrence and second primary tumors in a large cohort of patients treated for oral cavity cancer.

Marieke BrandsElisabeth A J SmeekensRobert P TakesJohannes H A M KaandersAndre L M VerbeekMatthias A W MerkxSandra M E Geurts

Published in: Cancer medicine (2019)

Our findings support a follow-up time of 2 years after curative treatment for OSCC. Based on the risk of recurrence there is no indication for a different follow-up protocol after first and second events. After 2 years, follow-up should be tailored to the individual needs of patients for supportive care, and monitoring of late side-effects of treatment.

Keyphrases

prognostic factors
end stage renal disease
randomized controlled trial
newly diagnosed
palliative care
papillary thyroid
free survival
combination therapy
chronic pain
patient reported outcomes
pain management
health insurance
squamous cell
affordable care act